SPIMACO eyes 10% market share in 2 years

12/03/2018 Argaam

 

Saudi Pharmaceutical Industries & Medical Appliances Corp. (SPIMACO) seeks to boost its Saudi market share to 10 percent over the coming two years, CNBC reported, citing chief executive Fahad bin Ibrahim Al Khalaf.

 

The company currently holds an 8 percent share, Al Khalaf said, adding that the Saudi pharmaceutical market is worth around SAR 30 billion.

 

SPIMACO presently has more than 15 strategic partnerships with global players, Al Khalaf noted.

 

Last Thursday, the Saudi firm signed a memorandum of understanding (MoU) with AstraZeneca UK Limited to locally produce a number of cancer medicines in SPIMACO’s pharmaceutical plant in Qassim.

 

Under the agreement, the production of 17 drugs used in cancer treatments will be completely nationalized.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.